Mononucleosis Diagnostic Market to Exhibit an Incredible Growth Rate of 5.00% by 2029, Size, Share, Trends, Key Drivers, Demand and Opportunities
Data Bridge Market Research recently conducted an in-depth market intelligence study, thoroughly examining the Mononucleosis Diagnostic Market. The freshly published report features an attractive layout that effectively conveys essential information through visually engaging tables, graphs, charts, and figures.
The Mononucleosis Diagnostic market report provides one of the most comprehensive solutions for understanding the trends and opportunities within the Mononucleosis Diagnostic industry. This report offers a holistic view of the market, with comprehensive insights and analysis. Within the Mononucleosis Diagnostic market research report, you will find a wide array of features relevant to the Mononucleosis Diagnostic industry, including general market conditions, trends, tendencies, key players, opportunities, and geographical analysis. Furthermore, this report offers a superior market perspective concerning product trends, marketing strategies, future product developments, new geographical markets, upcoming events, sales strategies, and customer behaviors.
Data Bridge Market Research analyses that the mononucleosis diagnostic market which is expected to reach at a CAGR of 5.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-mononucleosis-diagnostic-market
The Mononucleosis Diagnostic report encompasses a thorough analysis and assessment of various market-related factors that are pivotal for informed decision-making. In addition, competitive analysis is a key component of the Mononucleosis Diagnostic report, providing insights into the major players in the market and aiding businesses in making informed decisions to enhance their products and sales. Moreover, this Mononucleosis Diagnostic research report takes into account various industry aspects, including company profiles, player contact information, product specifications, geographical scope, production values, market structures, recent advancements, revenue analysis, market shares, and potential sales volumes for each company.
According to the Centers for Disease Control and Prevention, there were approximately 23,780 incident cases of infectious mononucleosis (IM) between 2002 and 2018, for an overall incidence rate of 104.2 cases per 100,000 person-years (p-yrs). The prevalence of IM diagnoses was highest among the youngest age groups and decreased with age. When compared to other race/ethnicity groups, non-Hispanic white service members had a higher incidence rate of IM diagnoses (123.4 per 100,000 p-yrs). The incidence of IM diagnoses among recruits was 3.4 times that of other enlisted personnel (106.0 per 100,000 p-yrs) and 5.6 times that of officers (64.7 per 100,000 p-yrs). As a result of rising incidences of infectious mononucleosis (IM), the demand for its diagnosis rises, resulting in growth.
Key Growth Drivers:
- Technological advancements act as a promising driver
Various novel technological advancements are occurring that can diagnose the infection faster than available on the market. For instance, Roche announced in 2020 that the USFDA had approved the Cobas EBV test, the first in-vitro quantitative diagnostic test in the US for the diagnosis of EBV Epstein-Barr Virus. This is a huge success for the healthcare industry and professionals because it will make it much easier to monitor patients who are at risk from this virus because it will perform a large number of tests in a short period of time.
- Increasing adolescent population is laying the foundation for expansion
Increasing adolescent population globally is also one of the major factor leading to growth of the market as mononucleosis is most common among teens and adults. More than half of all adolescents globally live in Asia. South Asia has nearly 350 million adolescents than any other region. It is followed by East Asia and the Pacific with over 300 million. The adolescent population of either of these regions dwarfs that of any other region in the world. According to World Health Organization (WHO) report, there are nearly 1.2 billion adolescents (10-19 years old) worldwide. In some countries, adolescents account for a quarter of the population and the number of adolescents is expected to rise through 2050, mainly in low- and middle-income countries (LMICs) where close to 90% of 10- to 19-year-olds live.
The report outlines the involvement of key players, including:
Abbott (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Weizmann Institute of Science (Israel), Biotest AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Genzyme (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), BD (U.S.), DiaSorin Molecular LLC (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux (France), Siemens (Germany), Sekisui Diagnostics (U.S.), ELITechGroup (France), Cardinal Health (U.S.), Immunostics Inc. (U.S.), Meridian Bioscience (U.S.), Thermo Fischer Scientific Inc. (U.S.)
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-mononucleosis-diagnostic-market
Key Market Segmentation
Test Type (Epstein Barr Virus (EBV) Antibody Test, Monospot Test, Complete Blood Count Test), End-User (Hospitals, Laboratories, Others)
The Mononucleosis Diagnostic market report includes the following countries in different regions:
The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here’s an overview of the regions and the countries they include:
- North America: United States, Canada, and Mexico.
- Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
- Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
- Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
- South America: Brazil, Argentina, and other countries in South America.
TABLE OF CONTENTS
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Part 07: Five Forces Analysis
Part 08: Market Segmentation
Part 09: Customer Landscape
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
Part 16: Appendix
Get the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-mononucleosis-diagnostic-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-prurigo-nodularis-treatment-market
https://www.databridgemarketresearch.com/reports/global-mens-health-market
https://www.databridgemarketresearch.com/reports/global-adrenocorticotropic-hormone-acth-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com
Editor Details
-
Company:
- The Wire Times
